Physician profile
Mathieu Forgues
NPI 1508284209
$2,726.19
in general payments reported to CMS, 2019-2025
13 companies · $575 in 2025
The $575 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $167 · 2020: $121 · 2021: $155 · 2023: $1,563 · 2024: $146 · 2025: $575.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,202 · Food and Beverage: $1,082.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,202.44 |
| Food and Beverage | $1,081.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,723.11 | 2023-2025 | Fusion, Propel, Nuvent |
| Genzyme Corporation | $286.23 | 2024-2025 | |
| Smith+Nephew, INC. | $166.63 | 2019 | |
| Intersect Ent, INC. | $159.41 | 2020-2021 | |
| Depuy Synthes Sales INC. | $122.73 | 2025 | Trumatch |
| Stryker Corporation | $91.54 | 2020-2021 | |
| Glaxosmithkline, LLC. | $36.69 | 2023 | Nucala |
| Spirair, INC. | $35.70 | 2025 | |
| Olympus America INC. | $29.27 | 2024 | Smart, Olympus |
| Karl Storz Endoscopy-America | $25.86 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $24.54 | 2024 | Dupixent |
| Organogenesis INC. | $13.17 | 2021 | |
| Integra Lifesciences Corporation | $11.31 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mathieu Forgues listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.